share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  05/16 00:25
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 32 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $13,789.76, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale. The acquisition was made directly from the issuer and paid for in cash. This transaction follows a three-month period where a total of 10,449 shares were sold by the officer, generating gross proceeds of $4,414,711.53.
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 32 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $13,789.76, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale. The acquisition was made directly from the issuer and paid for in cash. This transaction follows a three-month period where a total of 10,449 shares were sold by the officer, generating gross proceeds of $4,414,711.53.
最新文件顯示,Vertex Pharmicals Inc.高管阿米特·薩赫傑夫定於2024年5月15日出售32股普通股。這些股票的總市值爲13,789.76美元,於2024年5月14日,即計劃出售的前一天,通過員工股票購買計劃(ESPP)收購。此次收購是直接從發行人處進行的,並以現金支付。此次交易是在三個月之後進行的,該高管共出售了10,449股股票,總收益爲4,414,711.53美元。
最新文件顯示,Vertex Pharmicals Inc.高管阿米特·薩赫傑夫定於2024年5月15日出售32股普通股。這些股票的總市值爲13,789.76美元,於2024年5月14日,即計劃出售的前一天,通過員工股票購買計劃(ESPP)收購。此次收購是直接從發行人處進行的,並以現金支付。此次交易是在三個月之後進行的,該高管共出售了10,449股股票,總收益爲4,414,711.53美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。